Pricing Log in Create free account
Saturday 17 October 2026 Export PHG’s income statement to Excel — free account

Koninklijke Philips N.V.

PHG Healthcare Medical Devices

Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024. In the quarter to June 2026, revenue grew 2.94%, EPS grew 56.7%, free cash flow grew 49.7% and total debt fell 9.93%, each against the same quarter a year earlier.

25.74 0.25 +0.98%
Market cap
$24.9B
P/E
18.8×
Fwd P/E
11.2×
Dividend yield
3.94%
F-score
7/9
Altman Z
1.98
Beneish M
−2.68
Dividend safety
55/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Koninklijke Philips N.V. (PHG) Business Profile

Updated before January 2025

Company Overview

Koninklijke Philips N.V. (commonly known as Philips) is a Dutch multinational corporation headquartered in Amsterdam, Netherlands. Founded in 1891 by Gerard Philips and his father Frederik, the company initially focused on manufacturing light bulbs. Over the years, Philips has evolved into a global leader in health technology, with a strong emphasis on innovation and sustainability. The company operates in over 100 countries and employs approximately 74,000 people worldwide as of 2023.

Philips is led by CEO Roy Jakobs, who assumed the role in October 2022. Under his leadership, the company has continued its strategic focus on health technology, aiming to improve the lives of billions of people globally. The company’s board of management and executive committee oversee its operations, ensuring alignment with its mission to make the world healthier and more sustainable through innovation.

Core Business Segments

Philips operates through three primary business segments:

1. Diagnosis & Treatment

This segment focuses on advanced diagnostic imaging, image-guided therapy, and healthcare informatics. Key products and services include:

  • Diagnostic Imaging: MRI systems, CT scanners, and X-ray systems.
  • Image-Guided Therapy: Interventional X-ray systems and related software.
  • Healthcare Informatics: Data analytics platforms and clinical decision support tools.

2. Connected Care

The Connected Care segment is dedicated to patient monitoring, telehealth, and emergency care solutions. Key offerings include:

  • Patient Monitoring Systems: Solutions for hospitals and home care settings.
  • Telehealth Solutions: Remote patient monitoring and virtual care platforms.
  • Emergency Care: Automated external defibrillators (AEDs) and emergency response systems.

3. Personal Health

This segment focuses on consumer health and wellness products. Key products include:

  • Oral Healthcare: Electric toothbrushes and oral hygiene products.
  • Personal Care: Shavers, trimmers, and hair removal devices.
  • Mother & Child Care: Breast pumps, baby monitors, and feeding products.

Business Model

Philips operates a hybrid business model that integrates products, software, and services to deliver comprehensive solutions. The company generates revenue through:

  • Product Sales: Selling medical devices, consumer health products, and diagnostic equipment.
  • Service Contracts: Offering maintenance, training, and consulting services for healthcare providers.
  • Software Subscriptions: Providing cloud-based platforms and analytics tools for healthcare data management.

Philips emphasizes long-term partnerships with healthcare providers, leveraging its expertise in technology and innovation to deliver value-based care. The company also invests heavily in research and development (R&D), allocating approximately 10% of its annual revenue to innovation.

Strategic Direction

Philips has outlined several strategic priorities for the future:

1. Growth in Health Technology

The company aims to expand its presence in the health technology sector by focusing on integrated solutions that combine hardware, software, and services. This includes enhancing its portfolio of AI-driven diagnostic tools and telehealth platforms.

2. Sustainability Goals

Philips is committed to becoming carbon-neutral in its operations by 2025. The company also aims to improve the lives of 2.5 billion people annually by 2030, including underserved communities.

3. Innovation in Emerging Markets

Philips plans to increase its footprint in emerging markets such as Asia, Africa, and Latin America. The company is developing affordable healthcare solutions tailored to the needs of these regions.

4. Expansion of Digital Health

The company is investing in digital health technologies, including AI, machine learning, and cloud-based platforms, to enhance patient outcomes and operational efficiency for healthcare providers.

Competitive Landscape

Philips faces competition from several global players across its business segments:

  • Diagnosis & Treatment: Competitors include Siemens Healthineers, GE Healthcare, and Canon Medical Systems.
  • Connected Care: Rivals include Medtronic, ResMed, and Masimo.
  • Personal Health: Competitors include Procter & Gamble (Oral-B), Panasonic, and Braun.

Despite intense competition, Philips differentiates itself through its integrated solutions, strong brand reputation, and commitment to sustainability.

Risk Factors

Philips faces several risks that could impact its business:

  • Market Dependence: A significant portion of revenue comes from the healthcare sector, making the company vulnerable to changes in healthcare policies and budgets.
  • Supply Chain Disruptions: Global supply chain challenges, including semiconductor shortages, could affect production and delivery timelines.
  • Regulatory Compliance: The healthcare industry is heavily regulated, and non-compliance could result in fines or product recalls.
  • Economic Uncertainty: Economic downturns or geopolitical tensions could impact consumer spending and healthcare investments.

Recent Developments

In recent years, Philips has introduced several innovations and strategic initiatives:

  • Sleep & Respiratory Care Recall: The company has been addressing a global recall of certain CPAP and ventilator devices due to potential health risks. Philips has committed significant resources to resolve the issue and restore customer trust.
  • AI-Powered Solutions: Philips launched new AI-driven diagnostic tools, including advanced imaging software and predictive analytics platforms.
  • Sustainability Milestones: The company achieved 100% renewable electricity usage in its operations and introduced circular economy initiatives to reduce waste.

Investment Considerations

Strengths:

  • Strong brand reputation and global presence.
  • Leadership in health technology and innovation.
  • Commitment to sustainability and social responsibility.
  • Diversified revenue streams across products, services, and software.

Risks:

  • Ongoing challenges related to the CPAP device recall.
  • Dependence on the healthcare sector and regulatory compliance.
  • Exposure to global economic and geopolitical risks.

Conclusion

Koninklijke Philips N.V. is a global leader in health technology, with a rich history of innovation and a strong commitment to sustainability. While the company faces challenges such as supply chain disruptions and regulatory compliance, its strategic focus on digital health, emerging markets, and integrated solutions positions it well for future growth. Philips remains a compelling choice for investors seeking exposure to the healthcare and technology sectors.